Differential effects of photodynamic therapy on morphologically distinct tumor cells derived from a single precursor cell

Cancer Letters

Volumn 268, Issue 2, 2008, Pages 244-251

  Kushibiki, Toshihiro ^a   Sakai, Makoto ^b   Awazu, Kunio ^b  

^a Frontier Research Base for Global Young Researchers   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Morphological heterogeneity; Photodynamic therapy; Talaporfin sodium; Tumor; VEGF

Indexed keywords

PHOTOSENSITIZING AGENT; TALAPORFIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL HETEROGENEITY; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGENY; PROTEIN SECRETION; SENSITIVITY ANALYSIS; STEM CELL;

CELL LINE, TUMOR; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; PHOTOCHEMOTHERAPY; PORPHYRINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48549087483     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.054     Document Type: Article

References (37)

1. Schuitmaker J.J., Baas P., van Leengoed H.L., van der Meulen F.W., Star W.M., and van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B 34 (1996) 3-12
2. Lightdale C.J., Heier S.K., Marcon N.E., McCaughan Jr. J.S., Gerdes H., Overholt B.F., Sivak Jr. M.V., Stiegmann G.V., and Nava H.R. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest. Endosc. 42 (1995) 507-512
3. Verma S., Watt G.M., Mai Z., and Hasan T. Strategies for enhanced photodynamic therapy effects. Photochem. Photobiol. 83 (2007) 996-1005
4. Buytaert E., Dewaele M., and Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 1776 (2007) 86-107
5. Foote C.S. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54 (1991) 659
6. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-508
7. Dougherty T.J. An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20 (2002) 3-7
8. Sitnik T.M., Hampton J.A., and Henderson B.W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer 77 (1998) 1386-1394
9. Henderson B.W., Busch T.M., Vaughan L.A., Frawley N.P., Babich D., Sosa T.A., Zollo J.D., Dee A.S., Cooper M.T., Bellnier D.A., Greco W.R., and Oseroff A.R. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res. 60 (2000) 525-529
10. Chen Q., Huang Z., Chen H., Shapiro H., Beckers J., and Hetzel F.W. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem. Photobiol. 76 (2002) 197-203
11. Engbrecht B.W., Menon C., Kachur A.V., Hahn S.M., and Fraker D.L. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res. 59 (1999) 4334-4342
12. Fingar V.H., Kik P.K., Haydon P.S., Cerrito P.B., Tseng M., Abang E., and Wieman T.J. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer 79 (1999) 1702-1708
13. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13 (2001) 167-171
14. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
15. Deininger M.H., Weinschenk T., Morgalla M.H., Meyermann R., and Schluesener H.J. Release of regulators of angiogenesis following hypocrellin-A and -B photodynamic therapy of human brain tumor cells. Biochem. Biophys. Res. Commun. 298 (2002) 520-530
16. Ferrario A., von Tiehl K.F., Rucker N., Schwarz M.A., Gill P.S., and Gomer C.J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60 (2000) 4066-4069
17. Jiang F., Zhang Z.G., Katakowski M., Robin A.M., Faber M., Zhang F., and Chopp M. Angiogenesis induced by photodynamic therapy in normal rat brains. Photochem. Photobiol. 79 (2004) 494-498
18. Schmidt-Erfurth U., Schlotzer-Schrehard U., Cursiefen C., Michels S., Beckendorf A., and Naumann G.O. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4473-4480
19. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
20. Shimada Y., Imamura M., Wagata T., Yamaguchi N., and Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 69 (1992) 277-284
21. Shimada Y., Maeda M., Watanabe G., Yamasaki S., Komoto I., Kaganoi J., Kan T., Hashimoto Y., Imoto I., Izawa J., and Imamura M. Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. Clin. Cancer Res. 9 (2003) 243-249
22. Rao J., and Otto W.R. Fluorimetric DNA assay for cell growth estimation. Anal. Biochem. 207 (1992) 186-192
23. Bai J., Nakamura H., Ueda S., Kwon Y.W., Tanaka T., Ban S., and Yodoi J. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest. J. Biol. Chem. 279 (1994) 38710-38714
24. Capella M.A., and Capella L.S. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J. Biomed. Sci. 10 (2003) 361-366
25. Merlin J.L., Gautier H., Barberi-Heyob M., Teiten M.H., and Guillemin F. The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells. Int. J. Oncol. 22 (2003) 733-739
26. Li W., Zhang W.J., Ohnishi K., Yamada I., Ohno R., and Hashimoto K. 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells. J. Photochem. Photobiol. B 60 (2001) 79-86
27. Tsai T., Hong R.L., Tsai J.C., Lou P.J., Ling I.F., and Chen C.T. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg. Med. 34 (2004) 62-72
28. Teiten M.H., Bezdetnaya L., Merlin J.L., Bour-Dill C., Pauly M.E., Dicato M., and Guillemin F. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells. J. Photochem. Photobiol. B 62 (2001) 146-152
29. Zhou S., Zong Y., Ney P.A., Nair G., Stewart C.F., and Sorrentino B.P. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 105 (2005) 2571-2576
30. Robey R.W., Steadman K., Polgar O., and Bates S.E. ABCG2-mediated transport of photosensitizers. Cancer Biol. Ther. 4 (2005) 187-194
31. Runnels J.M., Chen N., Ortel B., Kato D., and Hasan T. BPDMA-mediated photosensitization in vitro and in vivo: cellular adhesion and h1 integrin expression in ovarian cancer cells. Br. J. Cancer 80 (1999) 946-953
32. Rousset N., Vonarx V., Eleouet S., Carre J., Kerninon E., Lajat Y., and Patrice T. Effects of photodynamic therapy on adhesion molecules and metastasis. J. Photochem. Photobiol. B Biol. 52 (1999) 65-73
33. Dougherty T.J., and Marcus S.L. Photodynamic therapy. Eur. J. Cancer 28 (1992) 1734-1742
34. Luna M.C., Ferrario A., Wong S., Fisher A.M., and Gomer C.J. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res. 60 (2000) 1637-1644
35. Fidler I.J., and Hart I.R. Biological diversity in metastatic neoplasms: origins and implications. Science 217 (1982) 998-1003
36. Beyer D.C. Brachytherapy for recurrent prostate cancer after radiation therapy. Semin. Radiat. Oncol. 13 (2003) 158-165
37. Wheeler J.A., Zagars G.K., and Ayala A.G. Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression. Cancer 71 (1993) 3783-3787